Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Dubini

Showing results (31-40 of 50) with videos related to

Pageof 5
Sort By:
The Journal of Antimicrobial Chemotherapy|May 1, 1984
In-vitro antibacterial activity of Sch 25393, a fluorinated analogue of thiamphenicolG Marca, R Mattina, F Dubini, et al.
Archivio Italiano Di Patologia E Clinica Dei Tumori|July 1, 1970
[Chloroimipramine, in association with dibutyryl cyclic 3'-5' AMP , increases its stimulating effect on growth of the Ehrlich ascites carcinoma]R Bossa, F Dubini, I Galatulas, et al.
Journal of Chemotherapy (Florence, Italy)|December 1, 1992
Antibacterial, antimycotic and trichomonicidal activity of a new nitroimidazole (EU 11100)F Dubini, L Riviera, C Cocuzza, et al.
Arzneimittel-Forschung|November 1, 1986
Mutagenicity studies on tioproninF Dubini, P Sezzano, M A Berti, et al.
Il Farmaco; Edizione Pratica|October 1, 1987
Mutagenicity studies on PTT-119F Dubini, P Sezzano, M A Berti, et al.
Journal of Chemotherapy (Florence, Italy)|October 1, 1991
Antifungal activity of two benzofuran-imidazoles in different experimental conditionsM G Bellotti, F Dubini, L Riviera, et al.
Il Farmaco; Edizione Pratica|June 1, 1980
[Normalizing effect of arginine thiazolidincarboxylate (ATCA) on hepatocytes in CCL4 poisoning in rats]A Marcucci, F Ferrario, R Carminati, et al.
Microbiologica|July 1, 1982
The fecal microbial population in the irritable bowel syndromeA Balsari, A Ceccarelli, F Dubini, et al.
International Journal of Antimicrobial Agents|August 10, 2000
Helicobacter pylori: ureA, cagA and vacA expression during conversion to the coccoid formF Sisto, M I Brenciaglia, M M Scaltrito, et al.
Journal of Chemotherapy (Florence, Italy)|June 1, 1993
Susceptibility of Helicobacter pylori and pharmacokinetic properties in mice of new 5-nitroimidazole derivatives devoid of mutagenic activity in the Ames testF Dubini, L Riviera, M M Scaltrito, et al.
Pageof 5

Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
The Journal of Antimicrobial Chemotherapy|May 1, 1984
In-vitro antibacterial activity of Sch 25393, a fluorinated analogue of thiamphenicolG Marca, R Mattina, F Dubini, et al.
Archivio Italiano Di Patologia E Clinica Dei Tumori|July 1, 1970
[Chloroimipramine, in association with dibutyryl cyclic 3'-5' AMP , increases its stimulating effect on growth of the Ehrlich ascites carcinoma]R Bossa, F Dubini, I Galatulas, et al.
Journal of Chemotherapy (Florence, Italy)|December 1, 1992
Antibacterial, antimycotic and trichomonicidal activity of a new nitroimidazole (EU 11100)F Dubini, L Riviera, C Cocuzza, et al.
Arzneimittel-Forschung|November 1, 1986
Mutagenicity studies on tioproninF Dubini, P Sezzano, M A Berti, et al.
Il Farmaco; Edizione Pratica|October 1, 1987
Mutagenicity studies on PTT-119F Dubini, P Sezzano, M A Berti, et al.
Journal of Chemotherapy (Florence, Italy)|October 1, 1991
Antifungal activity of two benzofuran-imidazoles in different experimental conditionsM G Bellotti, F Dubini, L Riviera, et al.
Il Farmaco; Edizione Pratica|June 1, 1980
[Normalizing effect of arginine thiazolidincarboxylate (ATCA) on hepatocytes in CCL4 poisoning in rats]A Marcucci, F Ferrario, R Carminati, et al.
Microbiologica|July 1, 1982
The fecal microbial population in the irritable bowel syndromeA Balsari, A Ceccarelli, F Dubini, et al.
International Journal of Antimicrobial Agents|August 10, 2000
Helicobacter pylori: ureA, cagA and vacA expression during conversion to the coccoid formF Sisto, M I Brenciaglia, M M Scaltrito, et al.
Journal of Chemotherapy (Florence, Italy)|June 1, 1993
Susceptibility of Helicobacter pylori and pharmacokinetic properties in mice of new 5-nitroimidazole derivatives devoid of mutagenic activity in the Ames testF Dubini, L Riviera, M M Scaltrito, et al.
Pageof 5